- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Jenburkt Pharmaceuticals confirmed compliance with share transfer agent regulations for the quarter ending March 31. The company's Registrar and Transfer Agent verified and processed all requests for converting physical shares to dematerialized form. This ensures that securities received were correctly handled, listed on the exchange, and investor records were updated promptly. This update reassures shareholders that the company maintains robust administrative processes for managing its share registry and investor services efficiently.